Bicalutamide (Sandoz Inc)
Welcome to the PulseAid listing for the Bicalutamide drug offered from Sandoz Inc. This Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc |
| NON-PROPRIETARY NAME: | Bicalutamide |
| SUBSTANCE NAME: | BICALUTAMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2009-07-06 |
| END MARKETING DATE: | 2017-12-31 |
Bicalutamide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Bicalutamide from Sandoz Inc |
| LABELER NAME: | Sandoz Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2009-07-06 |
| END MARKETING DATE: | 2017-12-31 |
| PRODUCT ID: | 0781-5409_3eb98793-cc6f-4ccb-a7fb-1abdf5252eae |
| PRODUCT NDC: | 0781-5409 |
| APPLICATION NUMBER: | ANDA078575 |
Other BICALUTAMIDE Pharmaceutical Manufacturers / Labelers:
